Shares of FibroGen (FGEN) jumped by a staggering 20.86% in 7 days from $20.81 to $25.15 at 20:19 EST on Thursday, after four successive sessions in a row of gains. NASDAQ Composite (FGEN) is jumping 0.78% to $14,020.33, following the last session’s downward trend,

FibroGen’s last close was $24.56, 57.07% under its 52-week high of $57.21.


Today’s last reported volume for FibroGen is 594327 which is 61.14% below its average volume of 1529389.

The company’s growth estimates for the present quarter is 52.6% and a drop 45.7% for the next.

FibroGen’s Revenue

Year-on-year quarterly revenue growth grew by 715.1%, now sitting on 176.32M for the twelve trailing months.


FibroGen’s last week, last month’s, and last quarter’s current volatility was a negative 1.07%, a positive 0.25%, and a positive 3.70%, respectively.

FibroGen’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.29% (last week), 2.31% (last month), and 3.70% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

FibroGen’s stock is considered to be oversold (<=20).

FibroGen’s Stock Yearly Top and Bottom Value

FibroGen’s stock is valued at $25.15 at 20:19 EST, way below its 52-week high of $57.21 and way above its 52-week low of $18.12.

FibroGen’s Moving Average

FibroGen’s value is way above its 50-day moving average of $21.36 and way below its 200-day moving average of $34.93.

Previous days news about FibroGen (FGEN)

According to Business Insider on Thursday, 10 June, "What You May DoIf you purchased securities and/or sold put options of FibroGen and would like to discuss your legal rights and how these cases might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (, or visit to learn more. ", "On this news, shares of FibroGen plummeted $14.90, or 43%, to close at $19.74 per share on April 7, 2021, on heavy volume."

More news about FibroGen (FGEN).


Please enter your comment!
Please enter your name here